2007
DOI: 10.1016/j.tetlet.2007.05.033
|View full text |Cite
|
Sign up to set email alerts
|

Preparation of large macrocyclic peptides using the oxime resin

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
9
0

Year Published

2007
2007
2018
2018

Publication Types

Select...
6

Relationship

2
4

Authors

Journals

citations
Cited by 10 publications
(9 citation statements)
references
References 17 publications
0
9
0
Order By: Relevance
“…Cyclizative cleavages of cyclopeptides, but not of cyclodepsipeptides, have been accomplished under a variety of reaction conditions. [34][35][36] After some experimentation (Table 2) we found a weakly acidic solution of DIEA (2.2 equiv.) and HOAc (5.5 equiv.)…”
Section: Solid-phase Synthesis On Kaiser Resinmentioning
confidence: 99%
“…Cyclizative cleavages of cyclopeptides, but not of cyclodepsipeptides, have been accomplished under a variety of reaction conditions. [34][35][36] After some experimentation (Table 2) we found a weakly acidic solution of DIEA (2.2 equiv.) and HOAc (5.5 equiv.)…”
Section: Solid-phase Synthesis On Kaiser Resinmentioning
confidence: 99%
“…Taking advantage of the dimerization side reaction of Kaiser Oxime resin, Tamaki et al . synthesized 3 by using a high level of loading resin to facilitate intercyclization in 1,4‐dioxane as a mediating solvent (Scheme ) …”
Section: Bacterial Antimicrobial Cyclopeptidesmentioning
confidence: 99%
“…Ta king advantage of the dimerization side reaction of Kaiser Oxime resin, Ta maki et al [135] synthesized 3 by using ah igh level of loading resin to facilitate intercyclization in 1,4-dioxane as amediating solvent (Scheme 2). [136] Ap owerful antibiotic that is representative of the head to side chain cycle topology is the polymyxin family.P olymyxin antibioticsa re isolated from the Gram-positive bacterium Paenibacillus polymyxa,a lso known as B. polymyxa,a nd comprise variousa nalogues, such as polymyxin B( PMB) and polymyxin E2 (colistin B( 4); Figure 3). [137] Colistini sr ich in the non-proteinogenic amino acid Dab;t hus conferring the molecule with additional stability against enzymatic degradation.C olistin shows aw ide range of activity against Gram-positive bacteria by interacting with lipopolysaccharide molecules in their outer membranes, causing an increase in cell membrane permeability,a nd hence,l eakage andc ell death.…”
Section: Homodetic Cyclic Peptidesmentioning
confidence: 99%
“…The different parameters affecting the cyclisation-oligomerisation reaction, whether to favor cyclic monomer or cyclic oligomers formation has been reported. 3 The synthesis of racemic Alloc-Ncy(Tmob)-OH, the resolution of its methyl ester and the demonstration of its application to form a norcysteine bridge in octreotide-amide using the Fmoc strategy on solid phase has been reported. N-Alloc and S-Tmob protection of norcysteine (Ncy) were found to be a preferred choice for Fmoc strategy over three other protected norcysteines synthesised.…”
Section: Solid-phase Synthesismentioning
confidence: 99%